Low Outlier
DEA Schedule CII

Strength

7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1

Manufacturer

Sandoz Inc.

NDC

00185209901

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA040439

On Market Since

6/14/2002

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-0.7%

3M

-1.2%

6M

+2.6%

1Y

-4.5%

3Y

-9.9%

5Y

N/A

All

+6.1%